Conceptio
›
Archive
›
ClinicalTrials.gov
ClinicalTrials.gov
public full text
Loss of RESponse to Ustekinumab Treated by Dose Escalation
Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW
· 2020
ClinicalTrials.gov · Datasets · License: Public Domain · 2020
Open Source ↗
crohn disease, dose escalation, ustekinumab, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia
#995650
Cryoablation With Pembrolizumab Or Avelumab In Urothelial Carcinoma
#995651
Sacituzumab Govitecan Plus EV in Metastatic UC
#995652
Effects of Multimodal Exercises Integrated With Cognitive-behavioral Therapy in Subjects With Chronic Neck Pain
#995653
Efficacy and Safety Study of SyB L-0501 for Patients With Multiple Myeloma
#995654
Record
· ID 874377
Retrieved via
Conceptio
— every document is proof-bundled with source, license, and retrieval metadata.